AEON Biopharma Expects $6.2 Million From Warrant Exercises
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
01:53:20 PM UTC
SquawkNews
AEON Biopharma entered into an amendment with holders of its two-year milestone warrants, reducing the exercise price for common shares to $0.20 per share and for pre-funded warrants to $0.1999 each. Certain participating holders agreed to exercise their warrants at the reduced prices, and the comp…